...
首页> 外文期刊>Annals of surgical oncology >Is a Prophylactic Central Compartment Neck Dissection Required in Papillary Thyroid Carcinoma Patients with Clinically Involved Lateral Compartment Lymph Nodes?
【24h】

Is a Prophylactic Central Compartment Neck Dissection Required in Papillary Thyroid Carcinoma Patients with Clinically Involved Lateral Compartment Lymph Nodes?

机译:是乳头状甲状腺癌患者所需的预防性中心隔间颈部剖检临床涉及侧腔淋巴结淋巴结?

获取原文
获取原文并翻译 | 示例
           

摘要

Background The 2015 American Thyroid Association guidelines state that a prophylactic central compartment neck dissection (PCND) should be considered for patients with papillary thyroid carcinoma (PTC) and clinically involved lateral neck lymph nodes (cN1b). The purpose of our study was to determine the rate of central neck recurrence in select cN1b patients, with no evidence of clinically involved central compartment lymph nodes, treated without a PCND. Methods After institutional review board approval, adult PTC patients with cN1b disease who were treated with a total thyroidectomy and lateral neck dissection were identified from an institutional database of 6259 patients who underwent initial surgery for well-differentiated thyroid carcinoma from 1986 to 2015. Patients with gross extrathyroidal extension, distant metastases, or no preoperative imaging were excluded. Patients with evidence of clinically involved central compartment lymph nodes, on preoperative imaging or intraoperative evaluation, also were excluded. A total of 152 cN1b patients were included and categorized into non-PCND and PCND groups. Central neck recurrence-free probability (CNRFP) was calculated using the Kaplan-Meier method and log-rank tests. Results One hundred three patients (67.8%) did not have a PCND. With a median follow-up of 65 months, the 5- and 10-year CNRFP was 98.4% in the non-PCND group and 93.6% in the PCND group (p = 0.133). Conclusions Select PTC patients with cN1b disease but no evidence of clinically involved central compartment lymph nodes, on preoperative imaging and intraoperative evaluation, appear to have a low rate of central neck recurrence. These patients may not require or benefit from a PCND.
机译:背景2015年美国甲状腺协会指南指出,对于甲状腺乳头状癌(PTC)和临床受累侧颈淋巴结(cN1b)患者,应考虑进行预防性中央腔室颈清扫(PCND)。我们研究的目的是确定在未经PCND治疗且无临床表现的cN1b患者中,中心颈部复发率。方法在机构审查委员会批准后,从1986年至2015年6259名因高分化甲状腺癌接受首次手术的患者的机构数据库中,确定患有cN1b疾病的成年PTC患者,他们接受了甲状腺全切除术和侧颈清扫术。排除甲状腺外明显延长、远处转移或无术前影像学检查的患者。在术前影像学或术中评估中,有证据表明中央室淋巴结临床受累的患者也被排除在外。共纳入152例cN1b患者,并将其分为非PCND组和PCND组。采用Kaplan-Meier方法和对数秩检验计算中心颈部无复发概率(CNRFP)。结果103例(67.8%)无PCND。中位随访时间为65个月,非PCND组的5年和10年CNRFP为98.4%,PCND组为93.6%(p=0.133)。结论:经术前影像学检查和术中评估,选择患有cN1b疾病但无临床表现的PTC患者,其中心颈复发率较低。这些患者可能不需要PCND或从中受益。

著录项

  • 来源
    《Annals of surgical oncology》 |2021年第1期|共7页
  • 作者单位

    Mem Sloan Kettering Canc Ctr Dept Surg Head &

    Neck Serv New York NY 10021 USA;

    Mem Sloan Kettering Canc Ctr Dept Surg Head &

    Neck Serv New York NY 10021 USA;

    Mem Sloan Kettering Canc Ctr Dept Surg Head &

    Neck Serv New York NY 10021 USA;

    Mem Sloan Kettering Canc Ctr Dept Med Serv Endocrinol 1275 York Ave New York NY 10021 USA;

    Mem Sloan Kettering Canc Ctr Dept Surg Head &

    Neck Serv New York NY 10021 USA;

    Mem Sloan Kettering Canc Ctr Dept Surg Head &

    Neck Serv New York NY 10021 USA;

    Mem Sloan Kettering Canc Ctr Dept Surg Head &

    Neck Serv New York NY 10021 USA;

    Mem Sloan Kettering Canc Ctr Dept Surg Head &

    Neck Serv New York NY 10021 USA;

    Mem Sloan Kettering Canc Ctr Dept Surg Head &

    Neck Serv New York NY 10021 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 外科学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号